Decision

Gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices

Effect: Passed
Result: 511 for · 1 against · 21 abstained roll call
Date: 25 April 2024, 13:19
Kind: New EU law · 1st reading

More facts (4)

Margin: by an overwhelming majority
Votes: 1 vote · 1 roll call
Sitting: Thursday 25 April 2024
Final vote: 168997

Margin: by an overwhelming majority
Votes: 1 vote · 1 roll call
Sitting: Thursday 25 April 2024
Final vote: 168997

Cite this page Roll-call results (EP)

Link to this page

Votes on this decision

Members on the final vote

Result

The final vote and what it means for this kind of decision.

Passed by an overwhelming majority.

Parliament adopted its position on the law.

Backed by The Left, Greens, S&D, Renew, EPP, ECR, Patriots and ESN.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
The Left	For 6	Against 0	Abst. 3	Majority line For	Clear line For
Greens	For 27	Against 0	Abst. 0	Majority line For	Clear line For
S&D	For 47	Against 0	Abst. 0	Majority line For	Clear line For
Renew	For 35	Against 0	Abst. 0	Majority line For	Clear line For
EPP	For 77	Against 0	Abst. 0	Majority line For	Clear line For
ECR	For 20	Against 0	Abst. 1	Majority line For	Clear line For
Patriots	For 19	Against 0	Abst. 0	Majority line For	Clear line For
ESN	For 3	Against 0	Abst. 0	Majority line For	Clear line For
No group	For 2	Against 0	Abst. 2	Majority line Tie	Clear line Divided

Voted against their group, 0

Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.

Nobody voted against a clear line of their group.

Countries

The final vote by national delegation.

The breakdown by country is not available right now.

Members

Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 533 members

All votes on this decision, 1

In voting order. **Result**: for–against–abstained (a show of hands has no count). **Requested by**: the groups that asked for a roll call, a split vote or a separate vote.
No.	Vote	Recorded	Result	Requested by
1	Final vote C9-0010/2024 - Proposition de la Commission	Roll call	511 for, 1 against, 21 abstained Adopted

Text

The text voted on.

Parliament’s vote records link no text to this decision.

Connections

What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.

No connections found for this decision.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/decisions/2024-04-25/1
Official sources: Roll-call votes, sitting of 25 April 2024 (European Parliament)
Results of votes, sitting of 25 April 2024 (European Parliament)
Data source: EP Open Data API: decisions of the sitting MTG-PL-2024-04-25
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices”. Decision, 25 April 2024. votingId 168997. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-04-25/1 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 25 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-25-RCV_EN.html; Results of votes, sitting of 25 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-25-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-25, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-25/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-decision-2024-04-25-1,
  author = {{European Parliament}},
  title = {{Gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices}},
  year = {2024},
  date = {2024-04-25},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-04-25/1}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-04-25/1},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 168997. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-25-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-25-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-25 (CC BY 4.0)}
}